The FDA cleared UpDoc V1.0 on December 23, 2025, the first Software as a Medical Device built around a patient-facing large language model, for managing insulin dosing in adults with type 2 diabetes.
A federal judge has ordered UnitedHealth to turn over internal documents about its nH Predict AI tool, which plaintiffs say denies Medicare Advantage extended-care claims that are reversed on appeal roughly 90 percent of the time.
Kintsugi Voice analyzes subtle acoustic patterns in short speech samples to screen for depression, part of a growing body of research into vocal biomarkers for mental health.
AI-Stroke's smartphone screening tool detected twice as many true stroke cases as standard paramedic checklists in a study of 2,000 emergency staff.
Pennsylvania's lawsuit against Character.AI over chatbots posing as licensed medical professionals could reshape how AI companion apps are allowed to talk about health.
A Swedish AI model that predicts molecular behavior in a fraction of the usual computing time could compress the costliest early stage of drug discovery.
UpDoc's FDA clearance for a patient-facing LLM medical device marks a regulatory first—and a test case for how far conversational AI can go in clinical care.
At WWDC 2026 Apple redesigned its Health app and rebuilt its heart-rate engine, but delayed Project Mulberry, its rumored AI health coach, saying it wanted more reliable biometric data first, even as Google's Gemini Health Coach already shipped in May.
Generate:Biomedicines has launched two global Phase III trials for GB-0895, an AI-engineered antibody for severe asthma dosed just twice a year, testing whether machine-designed biologics can clear the same bar as conventionally discovered drugs.
Genomics England's Generation Study is sequencing newborns' full genomes and using AI to sort millions of genetic variants into actionable results, catching rare treatable conditions in about 1 in 200 babies as the NHS plans a decade-long national rollout.